PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2022
                 Monthly information related to total number of voting rights and shares composing the share capital – March 31 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH to Present Novel Vesiculation Approach at the 24th Meeting of the European Red Cell Society
ERYTECH to Present Novel Vesiculation Approach at the 24 th M eeting of the European Red Cell Society Oral presentation detailing the feasibility of producing cargo-loaded extracellular vesicles derived from red blood cell s that have been loaded using the ERYCAPS® process, ERYCEV TM Cambridge, MA
View HTML
Toggle Summary ERYTECH to Participate in the Upcoming April Investor Conferences
ERYTECH to Participate in the Upcoming April Investor Conferences Cambridge, MA (U.S.) and Lyon (France), March 28 , 202 2 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red
View HTML
Toggle Summary ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 20 2 1 Conference call and webcast on Tuesday, March 14, 2022 at 8:30am EDT / 1:30pm CET          Progress towards seeking approval of GRASPA® for the treatment of ALL patients with hypersensitivity to pegylated
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2022
              Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website :
View HTML
Toggle Summary ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases Cambridge, MA (U.S.) and Lyon (France), February 8 , 202 2 – ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2022
                Monthly information related to total number of voting rights and shares composing the share capital – January 3 1 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI
ERYTECH Announces P resentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI Interim results from the Phase 1 rESPECT trial of eryaspase plus mFOLFIRINOX as first-line treatment for advanced pancreatic cancer patients , presented in a poster presentation, confirm
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2021
                Monthly information related to total number of voting rights and shares composing the share capital – December 3 1 , 2021. Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
ERYTECH to Participate in the Upcoming January Virtual Investor Conferences Cambridge, MA (U.S.) and Lyon (France), January 3 , 202 2 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances
View HTML
Top